O-RAN ALLIANCE Welcomes Four New OTICs In North America
The O-RAN ALLIANCE, fulfilling its mission to transform Radio Access Networks to be open, intelligent, virtualized and fully interoperable, today announced that it has approved four new Open Testing and Integration Centres (OTIC) in North America. OTICs are vendor-independent, open, and qualified labs approved by the O-RAN ALLIANCE that issue awards in the O-RAN Certification and Badging Program, so that operators can deploy products at scale and with confidence.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230817436719/en/
North American OTIC in the Boston Area (Northeastern University)
The OTIC at the Institute for the Wireless Internet of Things (WIoT) at Northeastern University promotes research, development, and testing of next-generation intelligent Open Radio Access Networks (Open RAN). The OTIC within the Open6G hub is a resource for industry, academia, and government toward multi-vendor interoperability and validation of end-to-end control logic for programmable networks, including artificial intelligence (AI) and machine learning (ML) algorithms. The OTIC provides testing equipment and services to validate disaggregated base stations and RAN Intelligent Controllers (RICs), including custom applications (i.e., xApps and rApps). Applications can be tested against different RAN implementations (including commercial and open-source stacks), in emulated or over-the-air environments. The OTIC platforms include Colosseum, the world’s largest wireless network emulator with hardware-in-the-loop, already showcased as a digital twin for multiple Open RAN tests and trials.
“Northeastern’s Open6G is at the forefront of innovation in Open RAN testing, architectures, algorithms, software, and experimentation. Together with our partners, we are creating an innovation and testing ecosystem that will continue to serve government, industry, and academia,” says Tommaso Melodia, Director of Northeastern University’s Institute for the Wireless Internet of Things.
North American OTIC in Central Iowa (ARA)
North American OTIC in Central Iowa (ARA) is hosted by the Center for Wireless, Communities, and Innovation (WiCI) at Iowa State University (ISU). It uses the newly deployed NSF funded ARA rural wireless platform and provides services for testing and integrating O-RAN technologies using state of the art wireless equipment and with the addition of agricultural and rural setting and equipment. To facilitate experimentation, ARA-OTIC has deployed multi-modal, long-distance, and high-capacity wireless x-haul platforms ranging from free space optical to mmWave and microwave bands, as well as advanced wireless access platforms such as low-UHF massive MIMO systems, software-defined-radio (SDR) and programmable commercial-off-the-shelf (COTS) 5G systems, and open-source 5G-and-beyond software platforms to integrate modeling and simulation environments as well as management and decision systems. ARA-OITC is fully committed to promoting the openness of O-RAN in research and innovation by providing a unique platform.
“We believe ARA-OTIC offers a unique platform for testing O-RAN equipment and services that will bring wireless innovation to AgTech and other rural industries,” said Professor Hongwei Zhang, Director of North American OTIC in Central Iowa (ARA).
North American OTIC in Salt Lake City (POWDER)
North American OTIC in Salt Lake City (POWDER) supports end-to-end Open RAN testing in lab and field scenarios and has developed a Testing Orchestration and Testing Automation (TOTA) framework to provide streamlined, on-demand testing capabilities. OTIC services provided by POWDER include interoperability and end-to-end testing, badging and certification. The OTIC offers additional Open RAN related services including use case and proof-of-concept development and evaluation, functional testing in lab and field environments, and Open RAN intelligent ecosystem research, testing and development.
“We are very pleased with POWDER’s OTIC designation,” said Kobus Van der Merwe, Professor in the Kahlert School of Computing and Director of the POWDER platform and the North American OTIC in Salt Lake City (POWDER). “Being an OTIC will allow POWDER to provide 5G/6G and specifically Open RAN testing, development and certification services, and form the basis for continued collaborative research efforts with industry partners. POWDER’s automated testing and lab-as-a-service features and the fact that POWDER provides both indoor and outdoor facilities are unique capabilities in this domain.”
North American OTIC in Washington, DC/Arlington, VA
The Commonwealth Cyber Initiative (CCI) xG Testbed at Virginia Tech, in partnership with AT&T, DISH Network, and Verizon, emphasizes programmability and interoperability, relying when possible on open interfaces and open-source software. Key capabilities include securing 5G and next-generation mobile networks, AI assurance, multi-vendor interoperability, conformance and performance testing, and an end-to-end intelligent RAN control-loop supported by an AI/ML framework. CCI’s OTIC features indoor and outdoor testing environments, which can validate disaggregated RAN components — O-RAN Centralized Unit (O-CU), O-RAN Distributed Unit (O-DU), O-RAN Radio Unit (O-RU) — Over-The-Air (OTA) across locations and transport networks. Researchers can test RAN components’ interaction with Radio Intelligent Controllers (RICs) and microservices/applications that are AI/ML-based (i.e., xApps and rApps). Related services include use case and proof-of-concept development and evaluation.
“The Commonwealth Cyber Initiative is committed to securing the next generation of wireless network technologies,” said Aloizio P. DaSilva, CCI xG Testbed director, North American OTIC in Washington, DC/Arlington, VA. “By conducting interoperability, conformance and performance tests as an OTIC site, we will identify and address key gaps, spurring innovation and early adoption in the wireless marketplace.”
“The O-RAN ALLIANCE welcomes four additional OTICs to North America, bringing the worldwide total to 15,” said Alex Jinsung Choi, Chairman of the Board, O-RAN ALLIANCE. “The essential function of OTICs to certify and badge products complements the work of our operator members and contributing vendors to continuously develop products and operationalize O-RAN specifications.”
About O-RAN ALLIANCE
The O-RAN ALLIANCE is a world-wide community of more than 300 mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, the O-RAN ALLIANCE’s mission is to re-shape the RAN industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN specifications enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN based mobile networks at the same time improve the efficiency of RAN deployments as well as operations by mobile operators. To achieve this, the O-RAN ALLIANCE publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations.
For more information, please visit www.o-ran.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230817436719/en/
Contact information
O-RAN ALLIANCE PR
Zbynek Dalecky
pr@o-ran.org
O-RAN ALLIANCE e.V.
Buschkauler Weg 27
53347 Alfter/Germany
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release
Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 16:30:00 EET | Press release
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r
Vertex Presents New Data on CASGEVY ® , Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 14:01:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and TDT ages 12 years and older, will be presented at the American Society of Hematology (ASH) Annual Meeting. CASGEVY is currently approved for eligible people ages 12 years and older with SCD or TDT in the United States, Great Britain, the European Union, the Kingdom of Saudi Arabia, the Kingdom of Bahrain, Kuwait, Qatar, Canada, Switzerland and the United Arab Emirates. “These results — the first clinical data ever presented on any genetic therapy for children ages 5-11 years with SCD — again demonstrate the tr
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 13:31:00 EET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 01:49:00 EET | Press release
Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive Officer, Lattice Semiconductor. The annual GSA Awards celebrate the accomplishments of the semiconductor indu
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
